Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
137 hedge funds and large institutions have $914M invested in Cardiovascular Systems, Inc. in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 12 closing their positions.
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
51% more capital invested
Capital invested by funds: $604M → $914M (+$310M)
7% more funds holding
Funds holding: 128 → 137 (+9)
6% more call options, than puts
Call options by funds: $2.37M | Put options by funds: $2.23M
2% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 46
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$11.3M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.3M |
| 3 |
BM
Bridger Management
New York
|
+$9.71M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.25M |
| 5 |
Millennium Management
New York
|
+$7.69M |
Top Sellers
CSII Hedge Fund Activity: Q2 2018 in Review
137 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2018, worth a combined $914M — up 51% from $604M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CSII positions and 12 closed out — a net gain of 9 holders — while 45 added to existing stakes and 46 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $11.3M. The largest seller was Wellington Management Group, cutting an estimated $20M.
- 137 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2018, up from 128 in Q1 2018.
- Funds reported $914M of Cardiovascular Systems, Inc. stock for Q2 2018, up 51% quarter-over-quarter.
- 21 funds opened new Cardiovascular Systems, Inc. positions in Q2 2018 and 12 closed out, a net change of +9 holders.
- The largest Cardiovascular Systems, Inc. buyer in Q2 2018 was Camber Capital Management, an estimated $11.3M added.
- The largest Cardiovascular Systems, Inc. seller in Q2 2018 was Wellington Management Group, an estimated $20M sold.
Based on aggregated 13F filings for Q2 2018.